Novartis

Global Economy

Novartis trims sales outlook after hit from Covid disruptions

The group's net income fell 4 percent to $1.9 billion, with sales down 1 percent at $11.35 billion for the three months to June 30

Coronavirus chronicle

Novartis to provide 'no profit' Covid-19 drugs to low income countries

World

Novartis faces key meeting in US bribery scandal after settling corruption case

Coronavirus chronicle

Novartis halts malaria drug trial against Covid-19 amid participant shortfall

Covid-19 in Bangladesh

Novartis donates safety gears to combat coronavirus

Coronavirus chronicle

Novartis inks deal to make Mass General Brigham's Covid-19 vaccine candidate

Coronavirus chronicle

Novartis, US regulators agree to malaria drug trial against Covid-19

Coronavirus chronicle

Malaria drug is biggest hope against coronavirus: Novartis CEO

World

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

World

Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker

Global Economy

US FDA says some data testing Novartis' $2 million gene therapy was manipulated